Affirm spinoff Resolve raised $60m from investors including its parent company, while sales and marketing software provider Qualified secured $51m in a Salesforce-backed round.

Columbia has taken an equity stake in the antiviral therapeutics producer, co-founded by two of its faculty members.

Samsung Ventures was part of a Silver Lake-led round that hiked health management app developer Noom's valuation to $3.7bn.

ANU Connect Ventures has participated in a series B round for Liquid Instruments, which builds on research at Australian National University.

Legend Holdings’s venture capital spinout has executed a secondary transaction to close its healthtech-oriented vehicle, LC Healthcare Continued Fund.

Access Biotechnology has returned for a series B round raised by Eliem Therapeutics, which emerged from stealth with $80m only two months ago.

Imec's venture capital arm has received $36.7m in capital from the Flemish government for its sophomore fund.

BioTheryX, Immuta and Pitch are among the companies that have raised fresh capital from corporates such as Intel Capital, Slack Fund, Citi Ventures and Dell Technologies Capital.

Bristol-Myers Squib and Mount Sinai Innovation Partners have helped the cancer therapeutics developer complete its series B round.

Theodorus has invested in Giiant Pharma’s $11m seed round.